Abstract Prevention of postoperative hepatic failure is important after hepatic resection. In patients with cirrhosis, impaired liver function and regenerative capacity after major hepatic resection are associated with increased morbidity and mortality. In this study, a combination of epidermal growth factor (EGF) and insulin were used as hepatotrophic factors in an attempt to stimulate DNA synthesis after 70% hepatectomy (HTX). Regenerative capacity was evaluated in normal and cirrhotic rat liver by measuring DNA synthesis in vivo. Micronodular liver cirrhosis was established by the simultaneous oral administration of CC14 and phenobarbital. Epidermal growth factor plus insulin was injected subcutaneously immediately after and 12 h after HTX or sham operation was performed. Rats were killed 24 h after the operation and liver regeneration was estimated by ['HI-thymidine incorporation into DNA as well as an autoradiographic nuclear labelling index. Hepatectomy increased [3H] -thymidine incorporation significantly in both normal and cirrhotic rats. In cirrhotic rats, ['HI -thymidine incorporation after HTX was significantly lower than in normal rats and administration of a combination of EGF and insulin after HTX enhanced [3H]-thymidine incorporation. In conclusion, DNA synthesis 24 h after HTX is decreased in cirrhotic rats compared with normal rats and EGF supplementation with insulin accelerates DNA synthesis in hepatectomized cirrhotic rats. The data suggest that administration of combinations of exogenous hepatotrophic factors may play a useful role in the treatment of cirrhotic patients undergoing major hepatic resection.
INTRODUCTION
Partial hepatic resection is a mainstay of treatment for liver tumours; however, many tumours arise in the setting of cirrhosis and diminished hepatic reserve. Normal liver usually has sufficient regenerative capacity to permit resection of up to 70% of the total liver cell mass. In liver cirrhosis, impaired liver function and poor regenerative capacity after hepatectomy (HTX) leads to increased morbidity and mortality.' '2 There have been few attempts to improve hepatic regeneration in the cirrhotic liver.394 Utilizing a rat liver model of micronodular cirrhosis, established by the simultaneous oral administration of carbon tetrachloride (CClJ and phenobarbital, supplemental transforming growth factor alpha (TGFa) enhanced liver regeneration as measured by in vivo [3H]-thymidine incorporation into DNA.4 Epidermal growth factor (EGF) is an hepatotrophic factor which promotes DNA synthesis in rat isolated hepatocytes and regenerating rat liver after 70% HTX5-7 and which shares amino acid homology with TGFa.' Epidermal growth factor has been shown to have synergistic effects on liver regeneration when supplemented with insulin or glucagon in normal rats in V~V O .~ To determine if EGF alone or in combination with insulin increased DNA synthesis in cirrhotic rat liver, hepatic regeneration was evaluated by measurement of liver DNA synthesis using two independent parameters, [3H]-thymidine incorporation into DNA and a nuclear labelling 
METHODS

Chemicals
Epidermal growth factor (fragment 20-31; EGF) and bovine insulin were purchased from Sigma Chemical 
Establishment of cirrhosis in a rat model
Male Wistar rats (150-2OOg) were obtained from Charles River Laboratories (Wilmington, MA, USA). Micronodular cirrhosis was established according to the method of Proctor and Chatamra, by the simultaneous oral administration of CCl, and phenobarbital, which increases the sensitivity of the liver to C C 4 by induction of the microsomal hydroxylating enzyme system." Rats were given phenobarbital sodium (35mddL) in drinking water. After treatment for 10-14 days with phenobarbital sodium, the rats weighed 250-300 g. The rats were anaesthetized with isoflurane and oxygen anaesthesia" and CCl, was administered once a week at midday using a curved feeding needle (16 gauge). After the beginning of CCl, feeding, bodyweight was measured daily. The initial dose of C C 4 was 0.04mL and successive doses were administered according to daily weight fluctuations in each rat. If bodyweight increased, the dose of CCl, was increased 0.04mL per week. If bodyweight decreased, administration of C C 4 was decreased to 0.02mL or stopped for the week. Administration of CCl, lasted for 10 weeks and phenobarbital was continued throughout the period of C C , gavage. Both CCl, and phenobarbital were discontinued at least 2 weeks before the operation.
Partial hepatectomy and sham operation
Cirrhotic and normal rats were anaesthetized by isoflurane/Oz anaesthesia" and subjected to sham operation or 70% hepatectomy. Sham rats were subjected to laparotomy and manipulation of the liver. Hepatectomy was performed after the method of Higgins and Anderson between 08:OO and 12:OOh and resected liver was weighed."
Measurement of DNA synthesis
Sham-operated and hepatectomized normal and cirrhotic rats were randomly placed in one of four groups. Group A, sham operated, no treatment (normal rats n = 9, cirrhotic rats n = 6); group B 70% HTX, no treatment (normal rats n=9, cirrhotic rats n=7); group C 70% HTX, subcutaneous injection of EGF (30nmoYkg) just after and 12h after 70% HTX (normal rats n = 3, cirrhotic rats n = 3); group D 70% HTX, subcutaneous injection of EGF and insulin (30 nmolkg and 0.2 nmol/kg) just after and 12 h after HTX (normal rats n=4, cirrhotic rats n=5).
All rats were killed 24 h after the Operation and the remnant liver and spleen were excised and weighed. Blood samples were collected from the inferior vena cava and serum albumin, total bilirubin and glucose were measured using commercial kits (Sigma Chemical Co., St Louis, MO, USA). Serum insulin was measured by radioimmunoassay as performed by the Michigan Diabetes Research and Training Center. Liver DNA synthesis 24h after hepatectomy was assessed using [3H]-thymidine incorporation.
[3H] -Thymidine was injected intravenously 1 h before the rats were killed.@ A 0.5 mL aliquot of liver homogenate (using a Douncetype homogenizer; Sigma) was precipitated with icecold 10% trichloroacetic acid twice and 70% ethanol once. To corroborate the observed results of [3H]-thymidine incorporation into DNA, autoradiographic analysis was performed and a nuclear labelling index was calculated. Tissue samples were fixed in 10% neutral-buffered formalin and embedded in paraffin blocks. Sections were cut, dipped in Kodak NTB-3 emulsion (Eastman Kodak, Rochester, NY, USA) and exposed for 4 weeks. Slides were developed in Dektol, counterstained with haematoxylin and eosin and analysed under the microscope with a 40x objective lens. Approximately 1000 nuclei were scored per experimental condition and the percentage of total nuclei positive for silver grains was used to calculate the labelling index.
statistical analysis
All values shown represent the mean + SEM. Student's t-test was used for comparing group means. The level of significance was accepted at P< 0.05.
RESULTS
Establishment of liver cirrhosis in rats
Thirty-four rats were treated with C C 4 and phenobarbital. These rats gained significantly less weight than untreated rats (Fig. 1 ). Overall mortality was 18% (6/34). All animals treated had macroscopic changes of the liver compatible with micronodular cirrhosis.
Ascites developed during CCl, treatment in five treated rats (15%) but disappeared when the dose of CCll was reduced or stopped.Three treated rats (9%) were noted to have ascites at the time of operation. Abdominal wall or intra-abdominal collateral vessels or a dilated splenic vein were observed in all rats. The overall effectiveness of this method for creating liver cirrhosis was 82% (28134). Figure 2 is representative of the typical microscopic features of cirrhosis found in these rat livers.
Characteristics of rats with liver cirrhosis
To corroborate the gross and microscopic features of cirrhosis in the treated rats, selected biological and biochemical parameters were measured ( Table 1) . T h e splenic weight of cirrhotic rats was greater than normal rats. Serum albumin of cirrhotic rats at time of death was less than normal rats. The serum total bilirubin of cirrhotic rats at death was greater than in normal rats.
Insulin levels in normal or cirrhotic rats subjected to 70% hepatectomy treated with EGF alone or EGF plus insulin were lower than in normal or cirrhotic shamoperated rats (Table 2 ). Subcutaneous injection of insulin (0.2 nmol/kg) had no effect on plasma insulin levels between EGF-treated rats and EGF plus insulintreated rats. T h e serum glucose level after death is shown in Table 2. T h e glucose level of rats treated with 70% HTX, EGF and insulin was significantly less than in normal sham rats. 
DNA synthesis after sham operation and 70% hepatectomy
Twenty-four hours after 70% HTX, [3H]-thymidine incorporation into the liver of normal rats was significantly increased from 100 f 3% (normal sham) to 928f 148%, which was 9.3-fold that of normal sham rats (Fig. 3a) . In rats with normal liver, exogenous EGF without supplemental insulin did not enhance [3H]-thymidine incorporation after 70% HTX (857 f 101%), whereas exogenous EGF with insulin did (1625f 519%), but not significantly (Fig. 3a) . After 70% HTX in cirrhotic rats, ['HI-thymidine incorporation into the liver also significantly increased from 77 f 8% (cirrhotic sham) to 284+59% (cirrhotic HTX), 3.7-fold that of cirrhotic sham rats (Fig. 3b) . These levels of [3H]-thymidine incorporation were significantly lower than in rats with normal liver (928 f 148%). The combination of exogenous EGF and insulin significantly improved [3Hl-thymidine incorporation in cirrhotic rat liver (284 f 59 vs 706 f 186%). Exogenous EGF alone had no growth-promoting effect on cirrhotic liver after 70% HTX (204 f 57% vs 284 f 59%).
Thymidine autoradiography
To support the results of [3H]-thymidine incorporation, autoradiography was performed and a nuclear labelling index was calculated for both normal and cirrhotic rat liver. Over 1000 nuclei were analysed in tissue sections of individual or duplicate rats with normal or cirrhotic liver subjected to sham or 70% HTX. In rats with normal liver subjected to sham or 70% HTX, the labelling index was < 1 and 23%, respectively. Qualitatively, no positive nuclei were seen in cirrhotic rats subjected to sham hepatectomy. In cirrhotic liver from 70% HTX, the labelling index was 5%. A further marked increase in the labelling index of liver from hepatectomized cirrhotic rats treated with supplemental EGF and insulin (14%) was also noted. Representative autoradiographs of regenerating cirrhotic rat liver treated with EGF and insulin or without treatment are shown in Fig. 4(a,b) .
DISCUSSION
Previous experiments using the cirrhotic rat model described in this report have shown a beneficial effect of transforming growth factor a (TGFa) on DNA syn- culation were similar to those seen in humans with cirrhotic liver and portal hypertension. Hypoalbuminaemia and hyperbilirubinaemia are compatible with impaired liver function as well as structure. In addition, the present study confirms impaired liver DNA synthesis after 70% HTX in this cirrhotic rat model. In normal liver, the rate of DNA synthesis after 70% HTX reaches a maximum at 24 h after operation and in cirrhotic liver the process of liver regeneration after 70% HTX was prolonged.'JJ4 In this study, ['HIthymidine incorporation into DNA 24h after 70% HTX was used to evaluate liver regenerati0n.Thi.s parameter has been established to be a useful indicator of the effect of growth factors on cell proliferation in a variety of experimental system^.^'^'^ To minimize variation in the specific activity of the lots of [3H]-thymidine used, ['HI-thymidine incorporation into DNA was expressed as a percentage of [3H] -thymidine incorporation into DNA of sham-operated normal rat liver and liver regeneration in both normal and cirrhotic rats could be evaluated quantitatively.
We hypothesized that EGF could be used as an hepatotrophic factor in cirrhotic rat liver. In the experiments reported here, the combination of EGF and insulin enhanced liver DNA synthesis in cirrhotic rats. Somewhat unexpectedly, treatment of rats with EGF alone (30nmoYkg) did not result in improved DNA synthesis after 70% HTX in normal or cirrhotic rats, which is consistent with the results of Olsen et aL7 Epidermal growth factor required supplemental insulin or glucagon to accelerate liver DNA synthesis after hepatectomy in normal rats;7 hence, treatment with EGF and insulin were used in this study. We chose the dose of EGF, 30 nmoYkg, in accordance with the 1iteratu1-e.~ Rasmussen et al. reported that a higher dose of EGF (48 nmoYkg) was ineffective, but that smaller doses can stimulate liver regeneration: the cause of this has not been elucidated. "Two normal non-hepatectomized rats (normal sham) were treated with EGF (30 nmol/kg) and insulin (0.2nmoYkg) and had a [3H]-thymidine uptake of 84 zk 17%, which indicated that this treatment did not stimulate DNA synthesis in non-HTX rats.
Although insulin is an hepatocyte growth modulator, a number of lines of evidence suggest that treatment with insulin alone has limited or no benefit in normal regenerating 1i~er.I~ Insulin is considered to be essential in liver regeneration and is transported into liver during the process of liver regeneration.I6 Insulin levels are reported to be high in cirrhotic patients and peripheral glucose metabolism suggests an impaired insulin response. I7,l8 Insulin-stimulated glycogen formation has been shown to be markedly impaired." D'Arville et d.
reported that insulin levels of CClJphenobarbitalinduced cirrhotic rats were not significantly altered when compared with phenobarbital-treated rats." Shankar et al. reported that insulin levels in thioacetamide-induced cirrhotic rats were significantly higher than in normal rats.*'There may be a disturbance of the uptake of insulin in cirrhotic liver, possibly by receptor-mediated mechanisms." After partial hepatectomy, insulin levels have been reported to decline and the administration of exogenous insulin results in little or no regenerative
In normal rats, decreased insulin and elevated glucagon levels have characterized the hepatic proliferative state.I6 In the present study, insulin levels in hepatectomized rats were significantly lower than in sham-operated rats with normal or cirrhotic liver and serum insulin and glucose levels were measured in treated and untreated normal and cirrhotic rats and found to be unchanged by the doses of insulin administered. Confirming the findings of the previously mentioned studies, insulin levels in cirrhotic sham rats were increased when compared with normal sham rats. The hyperinsulinaemia seen in these cirrhotic rats was not observed to have a cooperative effect with EGF in the acceleration of DNA synthesis. With regards to the effect of insulin alone on liver regeneration, one cirrhotic rat, treated preliminarily only with insulin (0.2 nmoYkg), had a ['HI-thymidine uptake level of 398% of the normal sham-control rat compared to salinetreated hepatectomized cirrhotic rats at a level of 284 * 59%. This was in contrast to the data on EGF and insulin, which gave a thymidine uptake value of 706f 186%. Due to this preliminary result and hyperinsulinaemia in cirrhotic rats, we did not use insulin alone on cirrhotic rats. 7~1 8 There are few studies which correlate the effect of hepatotrophic factors in cultured hepatocytes and in vim studies. In monolayer cultures of isolated hepatocytes, EGF alone has a stimulatory effect on DNA synthesis and EGF supplemented by insulin markedly accelerates DNA s y n t h e s i~.~~~~ The observed differences in the effects of EGF on isolated hepatocytes and hepatocytes in vivo are not well understood. Cellular density, or contact inhibition, the hormonal milieu and innervation of the liver in situ and damage during cell isolation might all play a role in the divergent responses seen in isolated hepatocytes and liver in viva Epidermal growth factor and TGFa are similar in that they share a 3344% homology in amino acid sequence and bind the same cell surface Transforming growth factor a has a limited effect on liver regeneration in normal rats, but does have a stimulatory effect in cirrhotic liver.4 Epidermal growth factor alone has no effect in cirrhotic liver. In vim, TGFa, acting in an autocrine manner, appears to be the physiological peptide hormone and EGF, acting via either an endocrine or paracrine mechanism, also appears to be the physiological peptide hormone.24iz5
The reasons for the disparity in the effects of EGF and TGFa are not known. The effects of EGF and TGFa on liver regeneration cannot be quantitatively compared, because the true physiological doses are not known. Further, although EGF and TGFa bind the same receptor in plasma membranes,' there is evidence that EGF and TGFa have different post-receptor pathways of signal transduction. Insulin appears necessary for normal signal transduction by EGF.26327 It is tempting to speculate that the transforming properties of TGFa in vim0 may be related to the lack of a requirement for additional regulatory factors, such as insulin. One potential drawback in the use of these growth factors in clinical trials is the potential for neoplastic transformation. Undetectable neoplasm or metastases in the remnant liver might be stimulated to grow by treatment of growth factors.
In conclusion, DNA synthesis 24 h after 70% HTX was significantly decreased in cirrhotic rats compared with normal rats. Combined treatment with EGF and insulin accelerated DNA synthesis in hepatectomized cirrhotic rats. Ultimately, such a combination of growth factor therapy may prove useful in the support of cirrhotic liver where regeneration must occur to allow patient survival.
